Introducing Zonisamide prepared according to the Zonegran standard—a broad‑spectrum anticonvulsant used for the treatment of partial onset seizures and certain generalized seizures. This formulation works by modulating voltage‑dependent sodium channels, inhibiting T‑type calcium channels, and enhancing GABAergic neurotransmission, thereby reducing seizure frequency and stabilizing abnormal neuronal firing. Additionally, Zonisamide may offer neuroprotective benefits and improved cognitive function. Experience enhanced seizure control, improved neurological stability, and an overall better quality of life with this advanced, targeted capsule therapy.